慢性閉塞性肺疾患およびリウマチ性関節炎:重度の悪化,肺炎,および人口ベースのコホートにおける死亡
C Hyldgaard1, B Bonnesen2, A K Vognsen2
1Medical Diagnostic Centre, University Clinic for Innovative Patient Pathways, Regional Hospital Central Jutland, Silkeborg, Denmark.
Scandinavian journal of rheumatology
|February 16, 2026
まとめ
リウマチ性関節炎 (RA) や慢性閉塞性肺疾患 (COPD) の患者は,肺炎のリスクが高まります. この発見は,RA患者のCOPD管理と予防戦略の強化の必要性を強調しています.
科学分野:
- 肺内科 肺内科 肺内科
- レウマトロジーの病理学
- エピデミオロジー エピデミオロジー
背景:
- リウマチ性関節炎 (RA) は死亡率の増加と関連しており,慢性阻害性肺疾患 (COPD) のような呼吸器疾患が重要な原因となっている.
- RAとCOPDの両方の患者さんが直面する特定のリスクを理解することは,患者のアウトカムを改善するために非常に重要です.
研究 の 目的:
- COPD (AECOPD) の重症急性悪化,肺炎,および,RAとCOPDの両方を有する患者の死亡率の比較リスクを,COPDのみを有する患者と比較して評価する.
主な方法:
- デンマークのCOPD登録からCOPD患者58,655人のコホートが特定され,そのうち2,033人がRAと診断されました.
- 国民保健レジストリーは,RAの診断,AECOPDと肺炎の入院,および生命状態に関するデータを提供しました.
- コックス比例危険性回帰は,治療加重の逆確率で調整され,12ヶ月のフォローアップ期間のアウトカムを比較するために使用されました.
主要な成果:
- この研究では,RAとCOPDの患者では,COPD単独の患者と比較して,AECOPD入院および死亡のリスクが類似していることが判明しました.
- しかし,RAとCOPDの両方を患っている患者は,肺炎で入院するリスクが著しく高かった (HR 1.26,95%CI 1.11-1.42).
- コホート全体の25%以上は,最初の1年以内にAECOPDおよび/または肺炎のために入院を経験しました.
結論:
- COPDのRA患者における肺炎のリスクの増加は,RAまたはその治療の免疫抑制効果に関連している可能性があります.
- これらの発見は,COPDの治療の最適化と,同時にあるRA患者のための標的型予防措置の実施の重要性を強調しています.
関連する概念動画
Chronic Obstructive Pulmonary Disease
2.6K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.9K
COPD: Pathogenesis and Clinical Features
1.9K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.9K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.8K
Chronic Obstructive Pulmonary Disease-I: Introduction
3.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.9K
Pneumonia I: Introduction
939
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
939


